Delivery Order SPE2DB22D3301-SPE2DB24FZ0CV

Award Date 7/9/24
Potential Completion Date 7/30/24
Potential Value $7.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The $3,360.71 firm fixed-price delivery order is for the pharmaceutical product PROMACTA 50 MG TABLET UU 14S, with a period of performance through May 6, 2024. Amerisourcebergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the...
The Defense Logistics Agency (DLA) awarded a $10,852.00 firm-fixed-price delivery order to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of PROMACTA 75 MG TABLET UU 30S, a pharmaceutical product. This order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of PROMACTA 75 MG TABLET UU 30S. The firm-fixed-price delivery order, valued at $10,852.00, supports the DLA's healthcare programs and has an ultimate completion date of October 16, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award, valued at $14,485.16, was granted by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is a Delivery Order for the supply of PROMACTA 50 MG TABLET, a pharmaceutical product, with a July 1, 2024 completion date. Amerisourcebergen, a major supplier of pharmaceutical products and medical supplies to the U.S. government, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This federal contract award, valued at $7,242.58, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of PROMACTA 50 MG TABLET medication and does not have a set-aside designation. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. This single-award IDC serves...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The $7,242.58 firm fixed-price delivery order is for the provision of PROMACTA 50 MG TABLET UU 30S, a prescription medication. This award is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,852.00 firm fixed-price delivery order is for the supply of PROMACTA 75 MG TABLET, a specialty medication. The contract has an ultimate completion date of November 12, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $32,579.74 firm fixed price delivery order is for the supply of PROMACTA 50 MG TABLET UU 30S, a specialty pharmaceutical product. This contract does not have a set-aside designation. The award supports the DLA's role in providing pharmaceuticals and medical supplies to...
This federal contract award, valued at $7,242.58, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is a Delivery Order for the supply of PROMACTA 50 MG TABLET UU 30S, a prescription medication. The contract has an ultimate completion date of September 16, 2024 and utilizes a Firm Fixed Price pricing type. This award does not have a set-aside designation. Amerisourcebergen Drug Corp's Corporate Office Division is the...
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price delivery order contract worth $7,242.58 to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the supply of PROMACTA 50 MG TABLET (National Drug Code 4565046823) and has a completion date of July 23, 2024. AmerisourceBergen, a major pharmaceutical distribution company, holds a larger Indefinite Delivery Contract (IDC) worth up to $999,999,999.00 with DLA Troop Support Medical through December 31, 2025....
  • SPE2DB22D3301
    Indefinite Delivery Contract
  • SPE2DB22D3301-SPE2DB24FZ0CV
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office Division. The contract, valued at $7,242.58, is a Firm Fixed Price Delivery Order for the supply of 4565098344 PROMACTA 50 MG TABLET UU 30S. There is no set-aside designation for this contract.

Amerisourcebergen, a major pharmaceutical distribution company, holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. Additionally, Amerisourcebergen holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024.

Generated 10/8/24, 9:02 AM